Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) is Pharmaceuticals in United States that focus on manufacturing drugs business. They cover business area such as manufacturer, seller, bio pharmaceutical product, drug, medical supply.
-
Manufacturing Drugs
-
1405 Research Boulevard
Rockville, MD 20850
United States
Private
manufacturersellerbio pharmaceutical productdrugmedical supply
* We use standard office opening hours in near Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) is Pharmaceuticals business from United States that founded in - ( years old in ), Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) business is focusing on Manufacturing Drugs.
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) headquarter office and corporate office address is located in 1405 Research Boulevard Rockville, MD 20850 United States.
Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) was founded in United States.
In , Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center) is currently focus on manufacturing drugs sector.
Above is snippet of Google Trends for "manufacturing drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aeras Global TB Vaccine Foundation (Biopharmaceutical Development Center), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
